通过激活AMPK信号通路,SIRT3通过抑制铁亡来缓解骨关节炎
Weiyu Tian1, Zijing Yang1, Mingkai Yu2
1Department of Orthopedic Surgery, The First Affiliated Hospital of Shihezi University, Shihezi 832002, China.
Cellular signalling
|August 16, 2025
概括
赛尔图因3 (SIRT3) 通过抑制铁亡和调节线粒体功能来保护骨关节炎 (OA). 准SIRT3-AMPK通路为OA治疗提供了一个有前途的治疗策略.
科学领域:
- 细胞生物学 细胞生物学
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- 骨关节炎 (OA) 涉及到软骨的退化和炎症,其中铁亡有助于软骨细胞死亡.
- 已知Sirtuin 3 (SIRT3) 激活可减少红细胞中的炎症和代谢反应,但其在铁亡中的作用尚不清楚.
研究的目的:
- 在炎症条件下研究SIRT3对状细胞铁亡的作用.
- 阐明涉及AMPK/mTOR信号通路的潜在机制.
主要方法:
- 门德尔的随机化分析了SIRT3表达和膝盖OA之间的关联.
- 在体外研究中使用了用炎症性细胞因子或铁亡调节剂治疗的ATDC5细胞,SIRT3过度表达.
- 在体内实验中使用了一种小鼠模型,该模型是通过介质半月体的不稳定引起的OA.
主要成果:
- 门德尔随机化表明SIRT3表达对膝关节OA具有保护性.
- 炎症刺激诱导了红细胞中的铁和氧化应激,降低了SIRT3.3的调节.
- 在体外和体内SIRT3过度表达改善了OA表型,减少了软骨退化和改善关节完整性,可能通过AMPK/mTOR途径.
结论:
- 通过AMPK/mTOR通路,SIRT3抑制铁亡并调节线粒体功能,缓解骨关节炎.
- SIRT3-AMPK轴代表了骨关节炎治疗的潜在治疗标.
相关概念视频
The JAK-STAT Signaling Pathway
9.2K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
9.2K
PI3K/mTOR/AKT Signaling Pathway
4.0K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
4.0K
TGF - β Signaling Pathway
7.6K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.6K
NF-κB-dependent Signaling Pathway
7.8K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.8K

